We've put some small files called cookies on your device to make our site work.
We'd also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We'll use a cookie to save your choice. You can read more about our cookies before you choose.
Clinical Commissioning Policy: Sodium oxybate for symptom control of narcolepsy with cataplexy (children and adolescents aged 7 until 19 years)
This clinical commissioning policy outlines the criteria when we will commission sodium oxybate for symptom control of narcolepsy with
cataplexy (children and adolescents, aged 7 until they are 19 years old).
